FDA VRBPAC meeting discussed boosters and future COVD-19 vaccines

At the US FDA’s April 6, 2022 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, they discussed “considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus for COVID-19 vaccines to address current and emerging variants.” – WATCH